首页|埃索美拉唑与奥美拉唑治疗反流性食管炎的临床效果分析

埃索美拉唑与奥美拉唑治疗反流性食管炎的临床效果分析

扫码查看
目的 探讨埃索美拉唑与奥美拉唑治疗反流性食管炎的临床效果。方法 选取2020年2月—2023年4月本院收治的58例反流性食管炎患者为研究对象,按照投掷硬币法分为两组,每组29例。参照组采用的治疗药物为奥美拉唑药物;研究组采用的治疗药物为埃索美拉唑药物。对比两组患者用药总有效率、生理指标缓解时间(胸骨后灼痛、嗳气反酸、进食梗噎感)、MNA评分(微型营养状态量表)、VAS评分(视觉模拟疼痛评分量表)、炎症因子指标评分[CRP(C反应蛋白)以及IL-6(白细胞介素-6)]。结果 与参照组比较,研究组患者临床疗效明显(P<0。05);与参照组比较,研究组患者胸骨后灼痛、嗳气反酸、进食梗噎感缓解时间缩短程度明显(P<0。05)。治疗前,研究组与参照组患者MNA评分、VAS评分差异不明显(P>0。05);治疗后,研究组与参照组患者MNA评分、VAS评分差异明显(P<0。05)。治疗前,研究组与参照组患者CRP、IL-6水平差异不明显(P>0。05);治疗后,与参照组比较,研究组患者CRP、IL-6水平降低程度明显(P<0。05)。结论 同奥美拉唑药物应用相比,临床合理使用埃索美拉唑药物治疗反流性食管炎,可将用药效果显著提升,将生理指标缓解时间有效缩短,改善患者炎性水平,具有更高的应用价值。
Clinical Effect Analysis of Esomeprazole and Omeprazole in Treatment of Reflux Esophagitis
Objective To explore value of esomeprazole and omeprazole drugs for patients with reflux esophagitis in clinical practice.Methods The paper chose 58 patients with reflux esophagitis in the hospital from February 2020 to April 2023for study,and divided them into groups with coin toss method.Reference group(29 cases)was treated with omeprazole,and study group(29 cases)with esomeprazole.Total effective rate of medication,physiological indicators relief time(burning pain behind the sternum,belching and acid reflux,choking sensation during eating),MNA scores(mini nutritional status scale),VAS scores(visual analogue pain scale),inflammatory factor index scores CRP(C-reactive protein)and IL-6(interleukin-6)were compared between two groups.Results Comparison of clinical effect showed,statistical results of patients with reflux esophagitis in study group had significant better than reference group(P<0.05).Statistical results of patients with reflux esophagitis in study group were significant lower than reference group in relief time of burning pain behind the sternum,belching and acid reflux,and choking sensation during eating(P<0.05).Before treatment,statistical results of MNA scores and VAS scores showed no significant difference in the statistical results between two groups,(P>0.05).After treatment,statistical results of MNA scores and VAS scores showed significant difference between two groups,(P<0.05).Before treatment,there was no significant difference in statistical results between study group and reference group in terms of CRP and IL-6 levels(P>0.05).After treatment,statistical results of CRP and IL-6 levels in study group were significant lower than reference group,(P<0.05).Conclusion During clinical practice of patients with reflux esophagitis,rational use of esomeprazole can more significantly improve medication effect,shorten the relief time of physiological indicators,improve inflammatory level of patients than omeprazole,which has higher application value.

EsomeprazoleOmeprazoleReflux esophagitisApplication effect

何秀银

展开 >

深圳精诚医疗集团如皋医院 消化内科,江苏 如皋 226500

埃索美拉唑 奥美拉唑 反流性食管炎 应用效果

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(9)
  • 14